These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6687896)

  • 1. Glutathione reductase deficiency and platelet dysfunction induced by 1,3-bis(2-chloroethyl)-1-nitrosourea.
    McKenna R; Ahmad T; Ts'ao CH; Frischer H
    J Lab Clin Med; 1983 Jul; 102(1):102-15. PubMed ID: 6687896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of erythrocytic glutathione reductase deficiency.
    Frischer H; Ahmad T
    J Lab Clin Med; 1987 May; 109(5):583-8. PubMed ID: 3572207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site-specific inhibition by 1,3-bis(2-chloroethyl)-1-nitrosourea of two genetically homologous flavoenzymes: glutathione reductase and lipoamide dehydrogenase.
    Ahmad T; Frischer H
    J Lab Clin Med; 1985 Apr; 105(4):464-71. PubMed ID: 3920338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity.
    Smith AC; Boyd MR
    J Pharmacol Exp Ther; 1984 Jun; 229(3):658-63. PubMed ID: 6726651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue.
    Maker HS; Weiss C; Brannan TS
    Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
    Frischer H; Kennedy EJ; Chigurupati R; Sivarajan M
    J Clin Invest; 1993 Dec; 92(6):2761-7. PubMed ID: 8254030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea].
    Frischer H; Ahmad T
    J Lab Clin Med; 1977 May; 89(5):1080-91. PubMed ID: 870569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
    Hohl RJ; Kennedy EJ; Frischer H
    J Lab Clin Med; 1991 Apr; 117(4):325-31. PubMed ID: 1901343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress.
    Moritz MW; Reimers RC; Baker RK; Sutera SP; Joist JH
    J Lab Clin Med; 1983 Apr; 101(4):537-44. PubMed ID: 6833826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
    Rice KP; Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathways.
    Karolak L; Chandra A; Khan W; Marks B; Petros WP; Peters WP; Greenberg CS; Hannun YA
    Mol Pharmacol; 1993 Jan; 43(1):37-44. PubMed ID: 8423767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes.
    Adamson GM; Billings RE
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):100-7. PubMed ID: 7682342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Wong M; Wells PG
    J Pharmacol Exp Ther; 1989 Jul; 250(1):336-42. PubMed ID: 2746506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner.
    Wang J; Pan S; Berk BC
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1283-8. PubMed ID: 17431186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of BCNU on glutathione metabolism in human blood cells].
    Benöhr HC; Waller HD
    Klin Wochenschr; 1979 Aug; 57(16):845-50. PubMed ID: 502351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of halothane on platelet function.
    Dalsgaard-Nielsen J; Gormsen J
    Thromb Haemost; 1980 Dec; 44(3):143-5. PubMed ID: 7466741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
    Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
    Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.